Humacyte's HAV for Femoro-Popliteal Bypass in Patients With PAD

Summary

This study will evaluate how well Humacyte's Human Acellular Vessel (HAV) works when surgically implanted into a leg to improve blood flow in patients with peripheral arterial disease (PAD). This study will also evaluate how safe it is to use the HAV in this manner.

Timeline

Start

2016-12-20

Primary completion

2020-12

Completion

2023-12

Drugs

Indications